the shareprice of ptd is diverging from fundamentals of anti-tnf drug. the sale of this drug will increase more thoughtout the next few years, with the approval of use for Crohn's disease. check out abott and jnj (abt, jnj) tickers in US stock exchange. if there is any doubt that the "Cancer" scare article will impact on sales, the share price would have been punished...
just a short term scare-good for the shorters but also good for long term buyers to buy it on the cheap....
PTD
unknown
